Register entry
ID Biomedical Corporation of Quebec
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 0
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| FLULAVAL 2026/2027 | influenza virus vaccine | suspension, intramuscular | 19515-822BLA |
Compare
Other companies listing influenza virus vaccine
- GlaxoSmithKline Biologicals SA19 sites · 126 NDC
Enquiry
Common questions
- Is ID Biomedical Corporation of Quebec FDA approved?
- ID Biomedical Corporation of Quebec holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does ID Biomedical Corporation of Quebec make?
- 1 product is listed under ID Biomedical Corporation of Quebec in the openFDA NDC Directory, most often as suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.